First Time Loading...

Inhibrx Inc
NASDAQ:INBX

Watchlist Manager
Inhibrx Inc Logo
Inhibrx Inc
NASDAQ:INBX
Watchlist
Price: 16.65 USD 2.52%
Updated: Jun 10, 2024

Inhibrx Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inhibrx Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Inhibrx Inc
NASDAQ:INBX
Net Change in Cash
$4.1m
CAGR 3-Years
-67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$11.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$218m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$21.9B
CAGR 3-Years
-140%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$126.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inhibrx Inc's Net Change in Cash?
Net Change in Cash
4.1m USD

Based on the financial report for Dec 31, 2023, Inhibrx Inc's Net Change in Cash amounts to 4.1m USD.

What is Inhibrx Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-67%

Over the last year, the Net Change in Cash growth was -97%. The average annual Net Change in Cash growth rates for Inhibrx Inc have been -67% over the past three years .